Marco Della Peruta

Title: Marco Della Peruta: Innovator in Cellular Technology

Introduction

Marco Della Peruta is a notable inventor based in London, GB. He has made significant contributions to the field of cellular technology, particularly in the development of innovative therapeutic approaches. His work focuses on enhancing the efficacy of immune responses through advanced cellular engineering.

Latest Patents

Marco Della Peruta holds a patent for a cell comprising a chimeric antigen receptor or a transgenic T-cell receptor, along with a chimeric TNF receptor. This invention relates to a cell that includes a chimeric antigen receptor (CAR) or a transgenic T-cell receptor (TCR), and a chimeric TNF receptor (TNFR) that features a binding domain capable of binding a TNFR ligand and a TNFR signaling domain. This patent represents a significant advancement in the field of immunotherapy.

Career Highlights

Marco Della Peruta is currently associated with Autolus Limited, a company that specializes in developing next-generation T-cell therapies for cancer treatment. His role at Autolus Limited allows him to apply his expertise in cellular technology to create innovative solutions for complex medical challenges.

Collaborations

Marco collaborates with various professionals in the field, including his coworker Martin Pulé. Their combined efforts contribute to the advancement of cellular therapies and the exploration of new treatment modalities.

Conclusion

Marco Della Peruta is a pioneering inventor whose work in cellular technology is paving the way for future advancements in immunotherapy. His contributions are vital to the ongoing development of effective cancer treatments.